Collegium Pharmaceutical, Inc. COLL

Updated: 17 Jun 2026

NASDAQ | Biotech | Specialty pharmaceuticals and pain management

No signal published yet

We already track Collegium Pharmaceutical and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Collegium Pharmaceutical free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Specialty pharmaceuticals and pain management
We're already tracking Collegium Pharmaceutical, Inc. — here are the latest events we've registered

Recent News

  • On May 12, 2026, Collegium completed the acquisition of AZSTARYS from Corium Therapeutics to strengthen its ADHD portfolio. The company also reported first-quarter 2026 net revenues of $193.5 million on May 7, 2026, representing a 9% increase year-over-year.

What Firelda Watch includes for Collegium Pharmaceutical, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Collegium Pharmaceutical, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL
Ionis Pharmaceuticals, Inc.
IONS
HOLD
Exelixis, Inc.
EXEL
HOLD

Biotech

More companies in this sector

Want to follow Collegium Pharmaceutical, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Collegium Pharmaceutical free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Collegium Pharmaceutical, Inc. COLL
Collegium Pharmaceutical — follow and we'll monitor it
Follow Collegium Pharmaceutical free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.